Skip to search formSkip to main contentSkip to account menu

talaporfin sodium

Known as: Taporfin Sodium 
An agent consisting of chlorin e6, derived from chlorophyll, and L-aspartic acid with photosensitizing activity. After intratumoral activation by… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND/AIM Photodynamic therapy (PDT) is an effective laser treatment for locally treating advanced bile duct carcinoma (BDC… 
2015
2015
Fluorescence spectra and fluorescence lifetime images of talaporfin sodium and sodium-pheophorbide a, which can be regarded as… 
2011
2011
Electrophysiological responses of rat myocardial cells to exogenous photosensitization reactions for a short period of incubation… 
2011
2011
Purpose: Historically, cutaneous photosensitivity has been the most common side effect of treatment with light‐activated drugs… 
2010
2010
OBJECTIVE Successful photodynamic therapy (PDT) requires high production of radical ions and singlet oxygen to kill target cells… 
2010
2010
The authors studied the application of photosensitization-reaction-induced cytotoxicity to establish electrical blockade of… 
2009
2009
BACKGROUND Mono-L-aspartyl chlorin e6 (Talaporfin sodium) is a novel photosensitizer, and is currently being used in photodynamic… 
2006
2006
We studied pulse energy density dependence of two distinctive clinical photosensitizers, Porfimer sodium and Talaporfin sodium… 
2005
2005
3663 Background: Recurrent or refractory liver metastases from colorectal cancer (CRC) leave few options after failure of…